180 Life Sciences Corp. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
180 Life Sciences Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • 180 Life Sciences Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$979K, a 72.3% increase year-over-year.
  • 180 Life Sciences Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$6.37M, a 63.9% increase year-over-year.
  • 180 Life Sciences Corp. annual Operating Income (Loss) for 2023 was -$13.5M, a 24.7% increase from 2022.
  • 180 Life Sciences Corp. annual Operating Income (Loss) for 2022 was -$17.9M, a 14.4% decline from 2021.
  • 180 Life Sciences Corp. annual Operating Income (Loss) for 2021 was -$15.6M, a 177% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$13.5M +$4.42M +24.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$17.9M -$2.26M -14.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$15.6M -$9.99M -177% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$5.65M +$15.2M +72.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$20.9M -$20.3M -3383% Jan 1, 2019 Dec 31, 2019 10-K 2021-07-09
2018 -$599K -$255K -74.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-07
2017 -$344K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.